-
1993
Company Description
FibroGen, a research-based biotech firm, uses its expertise CTGF and HIF biology to discover, develop, and commercialize novel therapeutics.
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs.
-
Manufacturer:
Science and Engineering -
Formed:
1993 -
Company Website:
-
Company E-mail:
-
Company Address:
409 Illinois St.San Francisco, CAUnited States -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits